Know Your Rights about Medication for Addiction Treatment!

This brochure explains the Federal laws that prohibit discrimination against individuals with disabilities and how they protect people receiving Medication Assisted Treatment for opioid addiction (also known as “MAT”).  MAT includes a medication (e.g., methadone, buprenorphine, oral naltrexone) approved by the U.S. Food and Drug Administration (FDA) for opioid addiction detoxification or maintenance treatment. 

https://www.samhsa.gov/sites/default/files/programs_campaigns/medication_assisted/Know-Your-Rights-Brochure.pdf 

Popular posts from this blog

Effective Treatments for Opioid Use Disorder — Finding Recovery and Staying Safe | NEJM

In this Double Take video from the New England Journal of Medicine and NEJM Knowledge+, Jennifer Foreman (Randolph Health Medical Group) and her son, = Dylan Glover, recount their journey through Dylan’s addiction and recovery. Ms. Foreman, along with Sarah Bagley (Boston Medical Center) and Scott Hadland (Massachusetts General Hospital for Children), reviews available medications for opioid use disorder and their mechanisms. They emphasize that multiple types of health care providers, including those in primary care, can manage and treat opioid use disorder. L.J. Punch (the T St. Louis, a harm-reduction program) also offers suggestions for harm reduction and guidance on how best to respond to an overdose.   https://youtu.be/KCtvjOiRFpU?si=dzX2nTP9DouM6QO1
Read more

The Concept of Treatment-Refractory Addiction: A Call to the Field

Not all patients respond to effective and approved treatment interventions, and there has been growing recognition in the medical field of these “resistant” or refractory illnesses (eg, treatment-resistant depression, resistant hypertension). In the field of substance use disorders, there has not been an explicit acknowledgement of treatment-refractory addiction (TRA) despite substantial evidence that many patients do not respond to standard-of-care treatment interventions. This article provides a justification for TRA as a critically important condition to recognize and define. TRA is not conceptualized as a diagnosis, but as a signal that a current treatment approach has not worked. The article addresses areas in need of research and consensus in order to ensure the approach to TRA is uniform, thoughtfully addressed, and data-driven. By explicitly acknowledging TRA, clinicians, researchers, and patients and their families can begin to explore the unique features of this population an...
Read more